LIFETIME BRANDS, INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data LIFETIME BRANDS, INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	593	579	705	735	769	863	728	687	683	648
Cost of revenue	376	364	449	480	495	560	467	432	422	407
Gross profit	217	215	256	255	274	303	260	255	261	241
Selling, general and administrative	130	141	163	162	156	156	155	153	160	142
Operating income	27.1	15.2	18.6	-23.4	25	50.8	24.3	31.9	27.1	-9.44
Interest expense	4.8	4.29	18	20.8	17.3	15.5	17.2	21.7	22.2	20
Pre-tax income	22	10.8	0.51	-43.8	5.55	36.4	9.03	10.5	-9.74	-30.2
Income tax	7.03	9.03	2.89	1.11	9.87	16.5	5.73	6.22	3.33	-3.28
Net income	15.7	2.15	-1.72	-44.4	-3.01	20.8	-6.17	-8.41	-15.2	-26.9
EBITDA	41.2	29.4	41.9	1.72	49.6	73.4	43.8	51.5	49.4	12.4
EPS, basic	1.11	0.15	-0.09	-2.16	-0.14	0.97	-0.29	-0.40	-0.71	-1.24
EPS, diluted	1.08	0.14	-0.09	-2.16	-0.14	0.94	-0.29	-0.40	-0.71	-1.24
Shares, basic (weighted)	14.2	14.5	19.5	20.6	20.9	21.4	21.6	21.2	21.5	21.7
Shares, diluted (weighted)	14.5	15	19.5	20.6	20.9	22	21.6	21.2	21.5	21.7
Dividend per share	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	7.88	7.6	7.65	11.4	36	28	23.6	16.2	2.93	4.27
Receivables	105	108	125	129	170	175	141	155	157	162
Inventory	135	132	174	173	203	271	222	189	202	194
Other current assets	8.8	10.4	10.8	14.1	12.1	11.5	13.3	16.3	11.5	12.1
Total current assets	256	258	319	329	421	485	400	376	374	374
Property, plant and equipment	21.1	23.1	25.8	28.2	23.1	20.7	18	17	15	15.4
Lease right-of-use assets				107	96.5	86.5	74.9	69.8	59.6	48.5
Goodwill	14.2	15.8	91.7	49.4	30.3	30.3	33.2	33.2	33.2	0
Intangible assets	75	72.7	247	231	214	182	181	166	150	133
Other non-current assets	1.89	1.75	1.84	4.07	2.47	1.79	6.34	3.1	2.6	1.79
Total assets	400	402	709	770	807	829	726	667	634	573
Accounts payable	29.7	25.5	38.2	36.2	66.1	82.6	38.1	54.2	60	45.8
Accrued liabilities	45.2	44.1	45.5	52.1	80.1	113	77.6	78.4	70.8	64.3
Short-term debt						5.77	0	4.74	4.89	5.02
Total current liabilities	91.3	71.5	84.9	107	180	214	130	152	152	131
Long-term debt						242
Lease liabilities				112	102	90.8	76.4	70	56.7	42.4
Other non-current liabilities	19	20.2	23.3	12.2	16.5	12.1	15	9.13	16	14.3
Total liabilities	202	191	429	534	577	573	486	436	404	370
Total debt			273	270		248	0	150	143	135
Paid-in capital	174	179	259	263	269	272	275	278	281	283
Retained earnings	61	60.5	55.3	7.17	0.42	17.4	1.15	-13.6	-32.6	-63.4
Other comprehensive income	-37	-29.3	-34.6	-34.5	-39.2	-33.5	-35.9	-33.5	-18.3	-18
Shareholders' equity	198	210	279	236	230	256	240	231	230	202
Total equity	198	210	279	236	230	256	240	231	230	202
Total liabilities and equity	400	402	709	770	807	829	726	667	634	573
Shares outstanding	14.6	14.9	20.8	21.3	21.8	22	21.8	21.8	22.2	22.7

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	15.7	2.15	-1.72	-44.4	-3.01	20.8	-6.17	-8.41	-15.2	-26.9
Depreciation and amortization	14.1	14.2	23.3	25.1	24.7	22.5	19.5	19.6	22.3	21.8
Stock-based compensation	2.94	3.39	4.14	5.04	5.95	5.22	3.85	3.69	3.92	3.3
Deferred income tax	-1.95	1.03	2.09	-1.07	-1.86	1.8	-3.83	-2.13	-2.04	-4.01
Change in receivables	-18	1.48	7.68	-2.1	-43.8	-5.53	33.9	-15	-3.21	-4.93
Change in inventory	4.49	10.8	-13.8	-7.46	-29	-67.5	47.4	35.4	-14.6	11.2
Cash from operations	29.7	17	19.2	29.9	44.8	37	24.3	56.4	18.6	7.61
Capital expenditures	-3.38	-6.31	-7.9	-9.17	-2.08	-3.99	-2.98	-2.8	-2.23	-4.35
Acquisitions	-21.7	0	-217	0	0	-0.18
Cash from investing	-24.4	-15.4	-224	-9.17	-2.08	-1.1	-20.9	-2.8	-2.23	-4.26
Stock issued	2.35	2.54	0.29	0.13	0.03	0.88	0.23	0	0
Share buybacks	-0.09				0	0	-6.32	-2.54	0	0
Dividends paid	-2.41	-2.48	-3.27	-3.57	-3.65	-3.84	-3.82	-3.73	-3.81	-3.78
Cash from financing	-4.17	-2.3	205	-16.9	-18.2	-44	-7.62	-61.1	-29.5	-2.21
Exchange rate effect	-0.38	0.38	-0.24	-0.06	0.1	0.16	-0.16	0.02	-0.11	0.2
Net change in cash	0.75	-0.28	0.05	3.72	24.6	-7.98	-4.38	-7.41	-13.3	1.34
Free cash flow	26.4	10.7	11.3	20.7	42.7	33	21.3	53.6	16.3	3.25
Interest paid	4.17	3.79	16.3	18.9	15.5	13.7	15.4	18.6	20	17.7
Income taxes paid	6.38	12.9	2.6	2.06	5.16	19	9.76	8.05	5.96	3.17

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $9.36 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	43.4%	Gross profit / revenue.
Operating margin	8.5%	Operating income / revenue.
EBITDA margin	11.7%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	5.7%	Pre-tax income / revenue.
Net margin	4.8%	Net income / revenue.
FCF margin	3.1%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	4.2%	Cash from operations / revenue.
Effective tax rate	16.0%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	14.6%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	5.2%	Net income / average total assets.
Return on invested capital (ROIC)	22.2%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	22.7%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.5%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	1.0%	Capital expenditures / revenue.
D&A / revenue	3.2%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-5.1%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-3.8%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	-3.4%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-7.7%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-2.6%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	-2.6%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-134.8%	Operating income vs the same period a year earlier. Only from a positive base.
EBITDA growth, 1y	-74.9%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-34.3%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	-24.2%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-59.0%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	-32.1%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	-29.9%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	-80.1%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	-46.6%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	-40.3%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	0.0%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	0.0%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	0.0%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	-12.0%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-5.6%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	-2.5%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-9.7%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-7.6%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-6.6%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	1.0%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	0.2%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	0.8%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	2.11x	Current assets / current liabilities.
Quick ratio	0.72x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.03x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.00x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	0.0%	Total debt / total assets.
Liabilities / assets	64.8%	Total liabilities / total assets.
Net debt	-$5.5M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	-0.07x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Working capital	$195.9M	Current assets - current liabilities.
Goodwill and intangibles / assets	0.0%	(Goodwill + intangible assets) / total assets.
Tangible book value	$217.5M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.07x	Revenue / average total assets.
Fixed asset turnover	27.8x	Revenue / average property, plant and equipment.
Inventory turnover	1.90x	Cost of revenue / average inventory.
Days inventory	192 days	365 x average inventory / cost of revenue.
Receivables turnover	5.47x	Revenue / average receivables.
Days sales outstanding	67 days	365 x average receivables / revenue.
Days payables	48 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	211 days	Days inventory + days sales outstanding - days payables.
FCF conversion	65.3%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	24.6%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$1.41	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$29.24	Revenue / diluted weighted shares.
FCF per share	$0.92	Free cash flow / diluted weighted shares.
Operating cash flow per share	$1.22	Cash from operations / diluted weighted shares.
Book value per share	$9.46	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$9.46	Tangible book value / shares outstanding.
Cash per share	$0.24	(Cash + short-term investments) / shares outstanding.
Payout ratio	12.1%	Dividends paid / net income, when net income is positive.
Dividends / FCF	18.5%	Dividends paid / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$215.2M	Share price x shares outstanding.
Enterprise value	$209.7M	Market cap + total debt - cash - short-term investments.
P/E	6.77x	Market cap / net income. Only when net income is positive.
P/S	0.33x	Market cap / revenue.
P/B	0.99x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	0.99x	Market cap / tangible book value, when positive.
P/FCF	10.4x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	7.81x	Market cap / cash from operations, when positive.
EV/Sales	0.32x	Enterprise value / revenue.
EV/EBIT	3.74x	Enterprise value / operating income, when both are positive.
EV/EBITDA	2.71x	Enterprise value / EBITDA, when both are positive.
EV/FCF	10.1x	Enterprise value / free cash flow, when both are positive.
FCF yield	9.7%	Free cash flow / market cap.
Earnings yield	14.8%	Net income / market cap (the inverse of P/E).
Dividend yield	1.8%	Dividends paid over the period / market cap.
Shareholder yield	1.8%	(Dividends paid + share buybacks) / market cap.

What was LIFETIME BRANDS, INC's revenue in fiscal 2025?

LIFETIME BRANDS, INC reported revenue of $647.9M for fiscal 2025, 5.1% lower than the year before.

Was LIFETIME BRANDS, INC profitable in fiscal 2025?

No. It reported a net loss of $26.9M.

How much free cash flow did LIFETIME BRANDS, INC generate in fiscal 2025?

Cash from operations of $7.6M minus capital expenditures of $4.4M left free cash flow of $3.3M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to LIFETIME BRANDS, INC